Cullinan, C A
Merck & Co., Inc., Rahway, NJ, USA (United States)
3 papers on CoChat
Most cited papers
- Verified
Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.
Berger, J., Bailey, P., Biswas, C., Cullinan, C. A., Doebber, T. W., Hayes, N. S., Saperstein, R., Smith, R. G., & Leibowitz, M. D. (1996) · Endocrinology
Peroxisome Proliferator-Activated ReceptorsMetabolism, Diabetes, and Cancer
Cited by 391
- Verified
Activation of PPARδ alters lipid metabolism in db/db mice
Leibowitz, M. D., Fiévet, C., Hennuyer, N., Peinado-Onsurbe, J., Duez, H., Berger, J., Cullinan, C. A., Sparrow, C. P., Baffic, J., Berger, G. D., et al. (2000) · FEBS Letters
Peroxisome Proliferator-Activated ReceptorsCholesterol and Lipid Metabolism
Cited by 308
- Verified
Glucose-dependent alterations of intracellular free calcium by glucagon-like peptide-1(7-36amide) in individual mouse β-cells
Cullinan, C. A., Brady, E. J., Saperstein, R., & Leibowitz, M. D. (1994) · Cell Calcium
Pancreatic function and diabetesDiabetes Treatment and Management
Cited by 29
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free